Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TBRG
TBRG logo

TBRG Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
15.080
Open
14.990
VWAP
14.70
Vol
118.71K
Mkt Cap
219.13M
Low
14.410
Amount
1.75M
EV/EBITDA(TTM)
6.30
Total Shares
15.01M
EV
367.61M
EV/OCF(TTM)
9.57
P/S(TTM)
0.62
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
Show More

Events Timeline

(ET)
2026-03-16
16:30:00
TruBridge Postpones Q4 2025 Earnings Release
select
2025-12-18 (ET)
2025-12-18
10:10:00
TruBridge Expands Exclusive Partnership with RevSpring
select
2025-11-06 (ET)
2025-11-06
16:58:36
TruBridge Adjusts FY25 Revenue Forecast to $345M-$348M, Aligning with Consensus of $347.27M
select
2025-11-06
16:57:43
TruBridge anticipates Q4 revenue between $86M and $89M, aligning with consensus of $88.78M.
select
2025-11-06
16:57:06
TruBridge announces Q3 adjusted EPS of 88 cents, surpassing consensus estimate of 47 cents.
select
2025-10-03 (ET)
2025-10-03
09:18:50
TruBridge appoints Michael Daughton as chief business officer
select
2025-09-23 (ET)
2025-09-23
09:18:04
TruBridge Enhances Collaboration with Java Medical Group
select
2025-08-07 (ET)
2025-08-07
20:54:37
TruBridge sees Q3 revenue $85M-$87M, consensus $87.8M
select

News

PRnewswire
7.0
03-24PRnewswire
Ademi LLP Investigates TruBridge for Possible Securities Fraud
  • Investigation Background: Ademi LLP is investigating TruBridge for possible securities fraud due to potentially inaccurate statements regarding its financial statements, business operations, and prospects, which may undermine investor confidence.
  • Financial Statement Issues: The investigation focuses on whether TruBridge's claims about revenue accounting, software development costs, and share-based payments were accurate, potentially exposing investors to financial losses.
  • Legal Consequences: Should the investigation confirm fraudulent activities by TruBridge, it could lead to class-action lawsuits, further impacting the company's stock price and market reputation, prompting investors to closely monitor developments.
  • Investor Action: Ademi LLP offers a no-cost opportunity for affected investors to join the investigation, emphasizing its commitment to protecting investor rights and encouraging those impacted to reach out for more information.
Newsfilter
7.5
03-24Newsfilter
AGH Integrates Microsoft Dragon Copilot to Enhance Patient Care
  • Documentation Burden Reduction: AGH's integration of Microsoft Dragon Copilot allows physicians to report a 50%-75% reduction in documentation time, significantly alleviating the clinical documentation burden and enabling healthcare providers to focus more on patient care, thereby enhancing service quality.
  • Real-Time Translation Feature: The system supports real-time communication with non-English-speaking patients, ensuring they can converse comfortably in their own language with the care team, which is particularly significant in multilingual communities and enhances the overall patient experience.
  • Multi-Party Recognition Technology: Dragon Copilot distinguishes between different individuals in the room, such as doctors, patients, and caregivers, automatically generating accurate transcripts of conversations, which ensures the completeness and accuracy of clinical information and improves the quality of medical records.
  • Leader in Digital Transformation: AGH's implementation of this technology showcases its leadership in the digital transformation of rural healthcare, emphasizing the critical role of technology in enhancing clinical efficiency and patient experience, further solidifying its core position in community healthcare.
Newsfilter
7.0
03-23Newsfilter
TruBridge Under Investigation for Possible Securities Law Violations
  • Delayed Financial Reporting: On March 16, 2026, TruBridge disclosed its inability to timely file its 2025 Annual Report due to identified errors in the consolidated financial statements for 2024 and out-of-period errors for multiple quarters in 2025, primarily related to revenue accounting, software development costs, and share-based payments, which may undermine investor confidence.
  • Significant Stock Price Drop: Following this announcement, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share on March 17, 2026, directly impacting investors' asset values and reflecting market concerns over the company's financial transparency.
  • Legal Investigation Initiated: The Law Offices of Howard G. Smith announced an investigation into TruBridge on behalf of investors to pursue potential claims for losses, indicating heightened scrutiny over the company's compliance and financial reporting, which could lead to further legal actions.
  • Investor Rights Protection: The law firm is urging affected investors to reach out for loss recovery, emphasizing the importance of actively protecting investor rights during financial distress, which may encourage more investors to engage in legal actions seeking compensation.
Globenewswire
7.0
03-23Globenewswire
TruBridge Faces Securities Claims Investigation
  • Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, which may expose shareholders to securities claims.
  • Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ended December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
  • Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and governance.
  • Legal Action Outlook: Investors may join the prospective class action without any out-of-pocket fees through a contingency fee arrangement, as Rosen Law Firm prepares to seek recovery of investor losses, emphasizing its commitment to protecting investor rights.
Globenewswire
7.0
03-21Globenewswire
TruBridge Faces Investor Lawsuit Investigation
  • Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating TruBridge, Inc. (NASDAQ:TBRG) for potential violations of federal securities laws and other unlawful business practices, indicating significant legal risks that could impact the company's market reputation.
  • Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 revealing its inability to timely submit its Annual Report for the fiscal year 2025 due to identified errors in prior financial statements, which may lead to decreased investor confidence in the company's financial transparency.
  • Significant Stock Price Drop: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's future performance and stability.
  • Investor Rights Advocacy: Bragar Eagel & Squire encourages affected investors to contact their attorneys to discuss legal rights, demonstrating a proactive approach to protecting investor interests, which may influence the trajectory of future legal proceedings.
Globenewswire
7.0
03-19Globenewswire
TruBridge Faces Securities Claims Investigation
  • Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, exposing shareholders to possible securities claims.
  • Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ending December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
  • Stock Price Decline: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share on March 17, 2026, reflecting market concerns regarding the company's financial transparency and credibility.
  • Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for investor losses, allowing participation without upfront fees, highlighting the uncertainty surrounding TruBridge's future financial health.
Wall Street analysts forecast TBRG stock price to rise
2 Analyst Rating
Wall Street analysts forecast TBRG stock price to rise
0 Buy
2 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
21.00
Averages
22.00
High
23.00
Current: 0.000
sliders
Low
21.00
Averages
22.00
High
23.00
RBC Capital
Sector Perform
maintain
$23
AI Analysis
2026-01-09
Reason
RBC Capital
Price Target
$23
AI Analysis
2026-01-09
maintain
Sector Perform
Reason
RBC Capital resumed coverage of TruBridge with a Sector Perform rating and $23 price target. TruBridge's opportunity to grow its Revenue Cycle Management business combined with its stable Electronic Health Records business is compelling, but RBC remains cautious on execution risk following recent periods of low growth, the analyst tells investors in a research note.
BMO Capital
Sean Dodge
Market Perform
initiated
$19.50
2025-11-12
Reason
BMO Capital
Sean Dodge
Price Target
$19.50
2025-11-12
initiated
Market Perform
Reason
BMO Capital analyst Sean Dodge initiated coverage of TruBridge with a Market Perform rating and $19.50 price target. The firm believes the company's realignment around revenue cycle management provides a more attractive growth opportunity versus the clinical software space. BMO expects to get positive on the shares as evidence of the company's traction becomes more apparent.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TBRG
Unlock Now

Valuation Metrics

The current forward P/E ratio for TruBridge Inc (TBRG.O) is 9.22, compared to its 5-year average forward P/E of 11.66. For a more detailed relative valuation and DCF analysis to assess TruBridge Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
11.66
Current PE
9.22
Overvalued PE
14.49
Undervalued PE
8.83

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.44
Current EV/EBITDA
6.22
Overvalued EV/EBITDA
10.07
Undervalued EV/EBITDA
6.81

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.03
Current PS
0.86
Overvalued PS
1.44
Undervalued PS
0.61

Financials

AI Analysis
Annual
Quarterly

Whales Holding TBRG

P
Paradigm Capital Management, Inc.
Holding
TBRG
+17.64%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is TruBridge Inc (TBRG) stock price today?

The current price of TBRG is 14.6 USD — it has decreased -1.82

What is TruBridge Inc (TBRG)'s business?

TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.

What is the price predicton of TBRG Stock?

Wall Street analysts forecast TBRG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TBRG is22.00 USD with a low forecast of 21.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is TruBridge Inc (TBRG)'s revenue for the last quarter?

TruBridge Inc revenue for the last quarter amounts to 86.11M USD, increased 1.66

What is TruBridge Inc (TBRG)'s earnings per share (EPS) for the last quarter?

TruBridge Inc. EPS for the last quarter amounts to 0.37 USD, decreased -160.66

How many employees does TruBridge Inc (TBRG). have?

TruBridge Inc (TBRG) has 3200 emplpoyees as of March 26 2026.

What is TruBridge Inc (TBRG) market cap?

Today TBRG has the market capitalization of 219.13M USD.